Biotechnology
GT Apeiron Therapeutics launched by GT Healthcare Capital Partners signs with Exscientia
SHANGHAI, June 11, 2019 /PRNewswire/ -- GT Apeiron Therapeutics ("Apeiron"), a novel biotechnology company, was launched with the backing from GT Healthcare and associated investors. The company also entered into a drug discovery collaboration with Exscientia, which utilizes artificial intellige...
2019-06-11 16:00
1980
Inovio Receives $8.14 Million Award to Support Further Development of its Commercial Skin Delivery Device
PLYMOUTH MEETING, Pennsylvania, June 10, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that the medical arm of the U.S. Defense Threat Reduction Agency (DTRA) will fund the further development of Inovio's new commercial intradermal delivery device. DTRA's Medical ...
2019-06-10 21:00
3022
Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal
HONG KONG, June 6, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-binding proposal l...
2019-06-06 18:00
8481
Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal
HONG KONG, June 6, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-binding proposal l...
2019-06-06 18:00
15880
Origin Agritech announces investment agreement with government investor to establish biotech commercialization joint venture.
BEIJING, June 5, 2019 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology and rural e-commerce company, today announced that the Company entered into a Cooperation Framework Agreement with Beijing Changping Technology Innodevelop Group (BC-TI...
2019-06-05 23:42
7684
Cellenkos, Inc. Initiates Phase 1 Clinical Trial of CK0801 for Treatment of Bone Marrow Failure Syndromes
HOUSTON, June 4, 2019 /PRNewswire/ -- Cellenkos, Inc., announced today the initiation of a Phase 1 Clinical Trial of CK0801, a first-in-class, allogeneic cord blood-derived T-regulatory cell product, for treatment of patients with bone marrow failure syndromes, including aplastic anemia, hypoplas...
2019-06-04 21:17
5723
Global Cord Blood Corporation Announces Receipt of Preliminary Non-Binding Proposal to Acquire the Company
HONG KONG, June 4, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that its board of directors has received a no...
2019-06-04 20:17
16766
Genecare partners with Jupiter Chain to release a secure online genetic profiling platform
SINGAPORE, June 4, 2019 /PRNewswire/ -- Genetics testing is the core of preventive healthcare. Clients must first understand their genetic makeup to lower the risks of developing an illness or disease. A leading ASEAN company, Genecare, is one genetics testing company that allows clients to bette...
2019-06-04 09:00
4579
Innovent Provides Update on ctDNA in Predicting Response and Resistance by Anti-PD-1 Therapy in Chinese Relapsed/Refractory Classical Hodgkin Lymphoma
SUZHOU, China, June 3, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the results of circulating tumor DNA (ctDNA) for predicting response and resistance ...
2019-06-04 08:00
3470
Innovent Provides Update on Sintilimab in Combination with CAPOX for First-Line Treatment of Patients with Gastric or Gastroesophageal Junction Carcinoma (GC/GEJC)
SUZHOU, China, June 4, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the preliminary results of efficacy and safety of sintilimab, the anti-PD-1 antibody...
2019-06-04 08:00
10705
Frost & Sullivan Publishes Q1 Update on Kadimastem
Continues its plans as expected; Ministry of Health approval for central experiment; financing is required to continue operations at the beginning of 2020; received Orphan Drug Designation from the FDA; target price unchanged. TEL AVIV, Israel, June 3, 2019 /PRNewswire/ -- The TASE analysis proje...
2019-06-03 21:24
1640
Chung Yuan Christian University plans to lead delegation of Taiwanese startups eyeing Australian market
TAIPEI, , June 3, 2019 /PRNewswire/ -- The Innovation & Incubation Center (IAIC), an arm of the Executive Operation Office for Industry-Academia Cooperation at Chung Yuan Christian University (CYCU) hosted the International Venture Capital Investment Match event onMay 27, 2019. Over 10 internatio...
2019-06-03 10:24
5092
Iovance Biotherapeutics Expands Partnership with WuXi Advanced Therapies Business
PHILADELPHIA, May 31, 2019 /PRNewswire/ -- Iovance Biotherapeutics, a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, has expanded its relationship with WuXi AppTec's Advanced Therapies Business Unit (WuXi ATU). Wu...
2019-05-31 20:00
2924
New NCCN Guidelines for Children with Cancer Meet Growing Needs of Pediatric Oncology Community Worldwide
New NCCN Guidelines® for Pediatric ALL include a strong focus on supportive care in order to reduce dangerous side-effects in children undergoing treatment for acute lymphoblastic leukemia, and share best practices for emerging treatments like immunotherapy, CAR T-cells, and targeted therapies. ...
2019-05-30 21:30
2321
Anpac Bio Presenting 'Unprecedented' Cerebral Cancer Liquid Biopsy Research Results at ASCO 2019
SACRAMENTO, California, May 30, 2019 /PRNewswire/ -- International life sciences corporation, Anpac Bio-Medical Science Company (Anpac Bio) Chief Executive Officer Dr.Chris Yu, announced today the company is presenting "unprecedented" cerebral cancer research results at theAmerican Society of Cl...
2019-05-30 20:00
3500
CartiHeal's Agili-C™ Implant Enhances In-vitro Osteogenic Differentiation of Human Bone Marrow-derived Mesenchymal Stem Cells
KFAR SABA, Israel, May 30, 2019 /PRNewswire/ -- CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of osteochondral and chondral defects, announced today the publication of anin-vitro study demonstrating that the Agili-C™ implant enhances osteogenic differentiation of human...
2019-05-30 20:00
2001
CytoDyn and Samsung BioLogics Formalize Manufacturing Partnership
INCHEON, South Korea, May 30, 2019 /PRNewswire/ -- CytoDyn Inc., a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications and Samsung BioLogics met at the Samsung BioLogics Songdo headquarters for an official ...
2019-05-30 19:00
2546
Thermo Fisher Scientific and Scinogy Partner to Accelerate Cell and Gene Therapy Commercialization
New collaboration will enable scalable, cost-effective manufacturing processes CARLSBAD, California, May 30, 2019 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today announced a collaboration with Scinogy, specialists in closed, automated manufacturing systems for...
2019-05-30 04:01
3228
PENTAX Medical launches MILES FOR HEALTH(TM) campaign to celebrate the 100-year anniversary of its origin
TOKYO, May 29, 2019 /PRNewswire/ -- PENTAX Medical
2019-05-29 22:00
2886
Singlera Genomics ColonES test selected as finalist for AACC Disruptive Technology Award
SAN DIEGO, May 29, 2019 /PRNewswire/ -- Singlera Genomics, which focuses on non-invasive early cancer detection through circulating tumor DNA methylation haplotyping analysis, was selected as one of three finalists for the second annual AACC Disruptive Technology Award. AACC Disruptive Technolo...
2019-05-29 21:00
1251
Week's Top Stories
Most Reposted
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 317 media titles]
2024-05-15 12:00
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 300 media titles]
2024-05-16 15:00
Central Embassy, celebrates its 10th anniversary with a world-class immersive presentation--the first of its kind in Thailand--by renowned artist Daniel Arsham
[Picked up by 272 media titles]
2024-05-10 15:20
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 271 media titles]
2024-05-16 09:39
Where does China's production capacity come from?
[Picked up by 258 media titles]
2024-05-10 12:01Most Read
Huawei Launching the All-Scenario Smart Telecom Power Solutions
2024-05-11 17:52
8458
Central Embassy, celebrates its 10th anniversary with a world-class immersive presentation--the first of its kind in Thailand--by renowned artist Daniel Arsham
2024-05-10 15:20
7826
Where does China's production capacity come from?
2024-05-10 12:01
7661
China Jo-Jo Drugstores Announces $2.74 Million Registered Direct Offering
2024-05-10 21:20
4950